The impact of SARS-CoV-2 in dementia across Latin America: A call for an urgent regional plan and coordinated response
Alzheimers Dement (N Y). 2020 Nov 23;6(1):e12092. doi: 10.1002/trc2.12092. eCollection 2020.
ABSTRACT
The SARS-CoV-2 global pandemic will disproportionately impact countries with weak economies and vulnerable populations including people with dementia. Latin American and Caribbean countries (LACs) are burdened with unstable economic development, fragile health systems, massive economic disparities, and a high prevalence of dementia. Here, we underscore the selective impact of SARS-CoV-2 on dementia among LACs, the specific strain on health systems devoted to dementia, and the subsequent effect of increasing inequalities among those with dementia in the region. Implementation of best practices for mitigation and containment faces particularly steep challenges in LACs. Based upon our consideration of these issues, we urgently call for a coordinated action plan, including the development of inexpensive mass testing and multilevel regional coordination for dementia care and related actions. Brain health diplomacy should lead to a shared and escalated response across the region, coordinating leadership, and triangulation between governments and international multilateral networks.
PMID:33283036 | PMC:PMC7683959 | DOI:10.1002/trc2.12092
Authors
Agustín Ibáñez, PhD
Neuroscientist
Hernando Santamaría-García, MD, MSc, PhD
Psychiatrist and Researcher
Alex Kornhuber
Photographer
Andrea Slachevsky, MD, PhD
Dominic Trépel, PhD
Assistant Professor of Health Economics
Elisa França Resende, MD, PhD
Neurologist
Ioannis Tarnanas, PhD, MSc
Neuroscientist
Jorge Llibre Guerra, MD, MS
Behavioral Neurologist
Laís Fajersztajn, PhD
Environmental Health Researcher
Maira Okada de Oliveira, PhD
Neuropsychologist
Maritza Pintado-Caipa, MD
Neurologist
Myriam De la Cruz Puebla, MD, PhDc
Neurologist & Scientist
Stefanie Piña Escudero, MD
Geriatrician
Tomás León, MD
Psychiatrist
Walter Dawson, DPhil
Health Policy Researcher
Bruce Miller, MD
Founding Director, University of California, San Francisco